Articles on Glioblastoma

Displaying all articles

Different genes drive cancer growth in males and females. Imagentle/Shutterstock.com

When it comes to brain tumors, a patient’s sex matters

Male and female tumors are different. Researchers are now hoping to exploit these sex-specific differences to treat brain cancer. This might improve survival for everyone.
James P. Allison and Tasuku Honjo win the 2018 Nobel Prize in Physiology or Medicine for their foundational work on cancer immunotherapy. The University of Texas MD Anderson Cancer Center and Kyoto University

2018 Nobel Prize in Physiology or Medicine: a turning point in the war on cancer

James Allison and Tasuku Honjo won the 2018 Nobel Prize in Physiology or Medicine for encouraging immune cells to attack cancer. See how their work has revolutionized cancer therapies and medicine.
Sen. John McCain pictured on July 27, 2017. McCain returned to Washington after surgery for glioblastoma to cast a ‘no’ vote to a Republican-backed bill to repeal Obamacare. Cliff Owen/AP Photo

Glioblastoma topples an American hero, but researchers will continue the fight

John McCain was known as a tough fighter and patriot, refusing to yield to his captors' torture while he was imprisoned as a POW. In the end, cancer claimed him. Researchers say progress is coming.
Sen. John McCain (R-Ariz.) returned to the Capitol July 25 to cast what was a tie-breaking vote to proceed to debate a bill to repeal Obamacare. AP Photo/Andrew Harnik

Glioblastoma, a formidable foe, faces a ‘reservoir of resilience’ in McCain

A diagnosis of glioblastoma did not keep John McCain from the Capitol to cast a crucial vote that could end Obamacare. His actions are a reminder that stats are one thing but human beings, another.
Glioblastomas are often resistant to the one type of drug that breaks the blood-brain barrier. HealthHub

Glioblastoma: why these brain cancers are so difficult to treat

Glioblastoma is an aggressive form of brain cancer that has a very poor prognosis. Despite the current best therapies half its sufferers survive for 15 months and less than 5% are alive after 5 years.

Top contributors

More